Sunday 11 October 2026
Export all SNY data to Excel Powerpack
Sanofi
SNY Healthcare Drug Manufacturers General
Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024. In the quarter to June 2026, revenue grew 17.4%, EPS fell 90.8%, free cash flow fell 45.1% and total debt rose 8.23%, each against the same quarter a year earlier. Dividend growth for three consecutive years.
40.07
0.16
−0.40%
Follow SNY
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
— | 7 | — | 6 |
| 0.00% | 10.94% | 0.00% | 5.87% | ||
| 7.01% | 6.16% | 6.06% | 3.21% | ||
ROIC |
6.17% | 6.57% | 6.12% | 6.58% | |
Return on Tangible Assets |
75.08% | 61.72% | 72.55% | 40.46% | |
Average Days of Receivables |
4.53 | 68.81 | 3.75 | 68.60 | |
Free Cash Flow per Share |
0.00 | 7.62 | 0.00 | 6.08 | |
Free Cash Flow |
— | 18,607.12 | — | 14,542.46 | |
Capital Expenditures |
— | (7,417.62) | — | (7,054.14) | |
| Other line items | |||||
Cash ROIC |
0.00% | 16.79% | 0.00% | 12.82% | |
Accounts Receivable Turnover |
9.30 | 5.55 | 105.97 | 5.69 | |
Accounts Payable Turnover |
0.76 | 1.79 | 0.62 | 1.90 | |
Inventory Turnover |
0.64 | 1.36 | 0.61 | 1.30 | |
Average Days of Payables |
732.11 | 205.90 | 630.21 | 195.73 | |
Days of Inventory on Hand |
815.34 | 285.70 | 652.28 | 304.59 | |
Tax Rate |
(0.18) | (0.17) | (0.17) | (0.22) | |
Research and Development Expense of Revenue |
18.12% | 16.79% | 16.43% | 16.58% | |
Selling, General and Administrative Expense of Revenue |
19.05% | 20.43% | 20.39% | 20.11% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
10.91 | 15.43 | 15.83 | 13.21 | |
Operating CF/Net income |
0.00 | 2.94 | 0.00 | 4.61 | |
Depreciation/Fixed assets |
0.00 | 1.22 | 0.00 | 1.30 | |
Capex/Depreciation |
— | (0.53) | — | (0.45) | |
Revenue per Share |
19.20 | 21.65 | 22.77 | 23.80 | |
Operating CF per Share |
0.00 | 10.66 | 0.00 | 9.02 | |
Capex per Share |
0.00 | (3.04) | 0.00 | (2.95) | |
Capex to Sales |
0.00 | 0.14 | 0.00 | 0.12 |
Columns are period end dates